Completion of 6-mo isoniazid preventive treatment among eligible under six children: A cross-sectional study, Lagos, Nigeria

Table 2 Treatment monitoring

	Variable	N	Percentage (%)
Commenced on isoniazid	Yes	262	100.0
1st mo WT (kg)	1-7	23	8.8
	8-15	170	65.4
	16-23	66	25.4
	24-31	1	0.4
1st mo Dose	< 100 mg	106	40.5
	150-200 mg	153	58.4
	250 mg and above	3	1.1
2nd mo WT (kg)	1-7	23	11.4
	8-15	122	60.4
	16-23	56	27.7
	24-31	1	0.5
2nd mo Dose	< 100 mg	87	41.4
	150-200 mg	121	57.6
	250 mg and above	2	1.0
3rd mo WT (kg)	1-7	15	7.9
	8-15	105	55.3
	16-23	69	36.3
	24-31	1	0.5
3rd mo Dose	< 100 mg	75	39.9
	150-200 mg	111	59.0
	250 mg and above	2	1.1
4th mo WT (kg)	1-7	12	7.3
	8-15	92	55.8
	16-23	57	34.5
	24-31	4	2.4
4th mo Dose	< 100 mg	67	38.5
	150-200 mg	106	60.9
	250 mg and above	1	0.6
5th mo WT (kg)	1-7	10	6.3
	8-15	91	57.2
	16-23	53	33.3
	24-31	5	3.1
5th mo Dose	< 100 mg	62	38.3
	150-200 mg	99	61.1
	250 mg and above	1	0.6
6th mo WT (kg)	1-7	6	4.1
	8-15	79	54.1
	16-23	56	38.4
	24-31	5	3.4
6th mo Dose	< 100 mg	55	35.5
	150-200 mg	99	63.9
	250 mg and above	1	0.6